A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...

Birmingham researchers funded by Cancer Research UK and liquid biopsy company Nonacus have developed a new urine test for bladder cancer, which could reduce the need for invasive and time-consuming ...

A range of other assessments besides the bladder pressure test work just as well in guiding treatment of female incontinence, researchers reported Saturday in The Lancet. Adobe stock/HealthDay A small ...

A urine test was shown to decrease the need for invasive cystoscopies in patients with non-muscle-invasive bladder cancer. A urine-based test may decrease the number of invasive cystoscopies in ...

Women with ongoing urinary incontinence could avoid invasive bladder pressure tests, as new research shows that a range of non-invasive assessments work just as well in guiding treatment. Led by ...

A urine test that detects proteins given off by malignant growths can identify bladder cancer faster and perhaps reduce the use of more invasive procedures, researchers said Tuesday. The $30 test that ...

Researchers have developed a test for urine, gathered during a routine procedure, to detect DNA mutations identified with urothelial cancers. Researchers at The Johns Hopkins Kimmel Cancer Center have ...

June 28 (UPI) --For patients with bladder cancer, a simple test can cut down on care costs, overtreatment and side effects, according to a study. Georgetown-led investigators said their test ...

A simple and cost-effective urine test could improve early detection and management of bladder cancer, according to a brief issued by the International Agency for Research on Cancer (IARC). This test ...

In a new study, researchers found that cystoscopy, the standard for screening for recurrence of early-stage bladder cancer, is a cost-effective method of detecting tumors. Adding other tests to ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc., (Nasdaq: VCYT) announced today the publication of new data demonstrating that the company’s Decipher Bladder genomic classifier accurately ...